Skip to content

Clinical trials

Glioma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Country / region: Australia Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20071
20091
20112
20121
20141
20151
20172
20183
20192
20205
20214
20227
20233
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Active, not recruiting13
Completed12
Terminated5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Nationwide Children's Hospital5
Novartis Pharmaceuticals4
Amgen3
Eli Lilly and Company3
Pfizer2
Aminex Therapeutics, Inc.1
AstraZeneca1
Blaze Bioscience Inc.1
Blueprint Medicines Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma45
Glioblastoma19
Astrocytoma16
Medulloblastoma10
Brain Neoplasms9
Diffuse Intrinsic Pontine Glioma9
Neuroblastoma9
Ependymoma8
Oligodendroglioma8
Rhabdomyosarcoma8

Trials

Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.